首页> 外文期刊>International journal of medical engineering and informatics >Molecular imaging for diagnosis and management of diabetes - A review
【24h】

Molecular imaging for diagnosis and management of diabetes - A review

机译:分子影像学在糖尿病诊断和治疗中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Diabetes incidence is increasing due to population growth, aging, urbanisation, and increasing prevalence of obesity and physical inactivity. This has spurred efforts to apply imaging techniques to gain better understanding of pathogenesis of diabetes. In particular, efforts have been focused on imaging the pancreatic islets for insulin-producing beta-cells. As insulin is the primary hormone involved in glucose regulation, variations in pancreatic beta-cell mass (BCM) are central to the etiology of diabetes. Location of pancreas and sparse distribution of beta-cells within the pancreas have thus far posed challenges in accurate BCM quantification for early diabetes detection. However, recent advances in the application of molecular imaging techniques exhibit potential in early detection and prevention of diabetes progression. They have been used with promising success for visualisation and quantification of BCM in experimental and clinical settings. We review the strengths and weaknesses of molecular imaging modalities as applied towards diagnosis and management of diabetes.
机译:由于人口增长,老龄化,城市化以及肥胖和缺乏运动的患病率增加,糖尿病的发病率正在增加。这刺激了应用成像技术以更好地了解糖尿病发病机理的努力。特别地,努力集中于对胰岛成像以产生胰岛素的β细胞。由于胰岛素是参与葡萄糖调节的主要激素,因此胰腺β细胞质量(BCM)的变化对于糖尿病的病因至关重要。迄今为止,胰腺的位置和胰腺内β细胞的稀疏分布已经对早期糖尿病的准确BCM定量提出了挑战。但是,分子成像技术应用的最新进展显示了早期发现和预防糖尿病进展的潜力。它们已成功地用于BCM在实验和临床环境中的可视化和定量。我们回顾了分子影像学方法在糖尿病诊断和治疗中的优缺点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号